“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »
CureVac’s late-stage COVID-19 vaccine trial flop clearly showed that not all pandemic shots are alike. But where does that leave the German biotech and its Big Pharma partners? For one, ongoing collaborations with Bayer and GlaxoSmithKline aren’t going anywhere for now, the companies said following the interim results drop late Wednesday. CureVac reported that its first-gen pandemic shot, known… Read More »
Prime Minister Scott Morrison announced on Friday it has terminated its $ 1 billion deal for the vaccine candidate being developed by the University of Queensland (UQ) and global biotech company CSL because trial participants were returning false-positive HIV test results. There were fears these results could undermine confidence in other vaccine candidates, so the… Read More »
Given increasing awareness of the link between diet and health, many patients are concerned that dietary factors may trigger dermatitis. Research has found that dietary factors can indeed exacerbate atopic dermatitis or cause dermatitis due to systemic contact dermatitis. In atopic dermatitis, dietary factors are more likely to cause an exacerbation among infants or children… Read More »
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More »